Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07180537 · ClinicalTrials.gov registry record · NA

Creating Health Course Study for People With Rheumatological Conditions

A NA study of Rheumatoid Arthritis and Systemic Lupus Erythematosus, sponsored by Terry L. Wahls.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT07180537: Recruiting NA study of Rheumatoid Arthritis and Systemic Lupus Erythematosus, sponsored by Terry L. Wahls.

NCT07180537 is a NA study of Rheumatoid Arthritis and Systemic Lupus Erythematosus that is actively recruiting participants, run by Terry L. Wahls. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07180537, a NA study of Rheumatoid Arthritis and Systemic Lupus Erythematosus, is actively recruiting participants, sponsored by Terry L. Wahls.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), psoriatic arthritis (PsA), Additionally, investigators will assess the program's effectiveness, as well as the challenges and facilitators involved in using an online wellness program to reduce fatigue and enhance the quality of life in patients suffering from these conditions.

Primary Outcome

Change in MFIS survey questions, scores range from 0-84, lower score is better.

Interventions

  • BEHAVIORAL Creating Health Online Course
  • BEHAVIORAL Delayed access to Creating Health Online Course

Study Locations (1)

Iowa

  • Univeristy of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-12-01
Est. Completion 2027-12-31
Phase NA
Terry L. Wahls

6 total trials

What NCT07180537 shows while recruiting

NCT07180537 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Creating Health Online Course is the first listed.

NCT07180537 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT07180537 about?

NCT07180537 is a clinical study titled "Creating Health Course Study for People With Rheumatological Conditions". The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tiss...

What is the current status of trial NCT07180537?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-12-01. Estimated completion is 2027-12-31.

What conditions does trial NCT07180537 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Psoriatic Arthritis, Sjogren's Syndrome, Mixed Connective Tissue Disease.

What interventions are being tested in trial NCT07180537?

The interventions under investigation include: Creating Health Online Course (BEHAVIORAL), Delayed access to Creating Health Online Course (BEHAVIORAL).

Who is sponsoring clinical trial NCT07180537?

This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07180537 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07180537's enrollment target sits among peer trials

200 84th of 197 higher than 110 of 197 other Rheumatoid Arthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07180537, the US trial registry maintained by the National Library of Medicine. NCT07180537 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.